Skip to main content
Clinical Trials/NCT02970110
NCT02970110
Completed
Not Applicable

Specimen Collection Study for H. Pylori Testing in Patients With Dyspepsia

Biomerica4 sites in 1 country98 target enrollmentFebruary 27, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Helicobacter Infections
Sponsor
Biomerica
Enrollment
98
Locations
4
Primary Endpoint
Non-invasive collection procedure
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The objective of this study is to acquire human specimens from subjects undergoing routine endoscopy with gastric biopsy for the diagnosis of active H. pylori infection.

Detailed Description

This is a prospective study designed to acquire and bank human specimens from subjects who are scheduled for routine upper endoscopy for symptoms such as dyspepsia. This study will be conducted at a minimum of 2 sites in the United States. Investigator sites will enroll prospective subjects who meet the inclusion / exclusion criteria. A case report form (CRF) provided by the sponsor will be used to capture basic demographic information (DOB, age, gender, race/ethnicity), medication history, and related clinical information. The CRFs will also record the results of the following tests performed with the gastric biopsy tissue specimens: histology and rapid urease test (RUT).

Registry
clinicaltrials.gov
Start Date
February 27, 2017
End Date
March 1, 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Biomerica
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Aged 21 and to 75 years.
  • Able to read, speak, and understand English or have access to a translator in subject's native language.
  • Patients without prior H. pylori eradication treatment.
  • Currently not on proton pump inhibitors, antibiotics or bismuth
  • Discontinuation at least 2 weeks prior to endoscopy and specimen collection.
  • Present with signs and symptoms of dyspepsia \[e.g. upper abdominal discomfort or pain\]
  • Undergo gastric biopsies as part of routine care
  • Physician able to provide histology and rapid urease result on biopsy specimens.

Exclusion Criteria

  • Aged less than 21 years old or older than 75 years
  • Unable to provide consent.
  • Patients with a history of prior H. pylori eradication therapy.
  • Currently on proton pump inhibitors, antibiotics or bismuth and cannot or will not discontinue
  • Previous upper gastrointestinal surgery, such as bariatric surgery, Nissen fundoplication, or Roux-en-Y.
  • Any unstable or poorly-controlled medical or psychiatric condition.

Outcomes

Primary Outcomes

Non-invasive collection procedure

Time Frame: 1 year

This study is designed to collect specimens to supplement repository specimens for product validation purposes. The endoscopy results and specimens will be used in a future clinical trial of a non-invasive in vitro diagnostic assay for the detection of H. pylori antigen. institutional review board approval is sought in order to be able to use human specimens for validation of in vitro diagnostics.

Study Sites (4)

Loading locations...

Similar Trials

Completed
Not Applicable
Detection of Gut Metabolites in Mother's Milk Following Juice IntakeHealthy Diet
NCT04596254Amazentis SA7
Completed
Not Applicable
Helicobacter Pylori Sample Collection Protocol Post Therapy SubjectsHelicobacter Pylori InfectionGastric UlcerNauseaAbdominal PainWeight LossStomach UlcerLoss of AppetiteBloating
NCT03060733DiaSorin Inc.13
Completed
Not Applicable
A Clinical Study on Endoscopic and Histopathological Outcomes of Screening and Surveillance ColonoscopiesColonic Polyp
NCT05869838Olympus Europe SE & Co. KG600
Completed
Not Applicable
Helicobacter Pylori Sample Collection Protocol Pre Therapy SubjectsHelicobacter Pylori InfectionGastric UlcerNauseaAbdominal PainWeight LossStomach UlcerLoss of AppetiteBloating
NCT03060746DiaSorin Inc.277
Completed
Not Applicable
Collecting Tumor Samples From Patients With Gynecological TumorsBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedChildhood Embryonal RhabdomyosarcomaChildhood Malignant Ovarian Germ Cell TumorEndometrioid Stromal SarcomaGestational Trophoblastic TumorMalignant MesotheliomaMalignant Ovarian Epithelial TumorMelanomaNeoplasm of Uncertain Malignant PotentialOvarian Brenner TumorOvarian Clear Cell CystadenocarcinomaOvarian Serous CystadenocarcinomaPaget Disease of the VulvaRecurrent Cervical CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Ovarian Germ Cell TumorRecurrent Primary Peritoneal CarcinomaRecurrent Uterine Corpus CarcinomaRecurrent Vaginal CarcinomaRecurrent Vulvar CarcinomaStage I Ovarian CancerStage I Uterine Corpus CancerStage I Vaginal CancerStage I Vulvar CancerStage IA Cervical CancerStage IA Fallopian Tube CancerStage IA Ovarian CancerStage IA Ovarian Germ Cell TumorStage IB Cervical CancerStage IB Fallopian Tube CancerStage IB Ovarian CancerStage IB Ovarian Germ Cell TumorStage IC Fallopian Tube CancerStage IC Ovarian CancerStage IC Ovarian Germ Cell TumorStage II Ovarian CancerStage II Uterine Corpus CancerStage II Vaginal CancerStage II Vulvar CancerStage IIA Cervical CancerStage IIA Fallopian Tube CancerStage IIA Ovarian CancerStage IIA Ovarian Germ Cell TumorStage IIB Cervical CancerStage IIB Fallopian Tube CancerStage IIB Ovarian CancerStage IIB Ovarian Germ Cell TumorStage IIC Fallopian Tube CancerStage IIC Ovarian CancerStage IIC Ovarian Germ Cell TumorStage III Borderline Ovarian Surface Epithelial-Stromal TumorStage III Cervical CancerStage III Uterine Corpus CancerStage III Vaginal CancerStage III Vulvar CancerStage IIIA Fallopian Tube CancerStage IIIA Ovarian CancerStage IIIA Ovarian Germ Cell TumorStage IIIA Primary Peritoneal CancerStage IIIB Fallopian Tube CancerStage IIIB Ovarian CancerStage IIIB Ovarian Germ Cell TumorStage IIIB Primary Peritoneal CancerStage IIIC Fallopian Tube CancerStage IIIC Ovarian CancerStage IIIC Ovarian Germ Cell TumorStage IIIC Primary Peritoneal CancerStage IV Borderline Ovarian Surface Epithelial-Stromal TumorStage IV Fallopian Tube CancerStage IV Ovarian CancerStage IV Primary Peritoneal CancerStage IV Uterine Corpus CancerStage IVA Cervical CancerStage IVA Vaginal CancerStage IVB Cervical CancerStage IVB Vaginal CancerStage IVB Vulvar CancerUterine Corpus CancerUterine Corpus LeiomyosarcomaVulvar Squamous Cell Carcinoma
NCT00897442Gynecologic Oncology Group275